BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 33970925)

  • 1. The association between the expression of nuclear Yes-associated protein 1 (YAP1) and p53 protein expression profile in breast cancer patients.
    Cha YJ; Kim D; Bae SJ; Ahn SG; Jeong J; Cho MK; Paik PS; Yoo TK; Park WC; Yoon CI
    PLoS One; 2021; 16(5):e0250986. PubMed ID: 33970925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Nuclear Expression of Yes-Associated Protein 1 Correlates With Metastasis in Patients With Breast Cancer.
    Cha YJ; Bae SJ; Kim D; Ahn SG; Jeong J; Koo JS; Yoo TK; Park WC; Lee A; Yoon CI
    Front Oncol; 2021; 11():609743. PubMed ID: 33718163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of YAP1 on clinical outcomes in human cancers.
    Wu Y; Hou Y; Xu P; Deng Y; Liu K; Wang M; Tian T; Dai C; Li N; Hao Q; Song D; Zhou LH; Dai Z
    Aging (Albany NY); 2019 Oct; 11(19):8681-8700. PubMed ID: 31613226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of nuclear localization of SHP2 and YAP1 with unfavorable prognosis in non-small cell lung cancer.
    Chen MJ; Wang YC; Wu DW; Chen CY; Lee H
    Pathol Res Pract; 2019 Apr; 215(4):801-806. PubMed ID: 30685130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yes-Associated Protein 1 as a Novel Prognostic Biomarker for Gastrointestinal Cancer: A Meta-Analysis.
    Zhang L; Song X; Li X; Wu C; Jiang J
    Biomed Res Int; 2018; 2018():4039173. PubMed ID: 30539010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Yes-associated protein 1 with concomitant negative LATS1/2 expression is associated with poor prognosis of advanced gastric cancer.
    Kim E; Ahn B; Oh H; Lee YJ; Lee JH; Lee Y; Kim CH; Chae YS; Kim JY
    Pathology; 2019 Apr; 51(3):261-267. PubMed ID: 30819540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Merlin expression and high Survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma.
    Meerang M; Bérard K; Friess M; Bitanihirwe BK; Soltermann A; Vrugt B; Felley-Bosco E; Bueno R; Richards WG; Seifert B; Stahel R; Weder W; Opitz I
    Mol Oncol; 2016 Oct; 10(8):1255-65. PubMed ID: 27378628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear expression of Yes-associated protein 1 correlates with poor prognosis in intestinal type gastric cancer.
    Song M; Cheong JH; Kim H; Noh SH; Kim H
    Anticancer Res; 2012 Sep; 32(9):3827-34. PubMed ID: 22993325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysis.
    Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Chikhlikar PR; Ghosh N; Trivedi TI
    Ann Surg Oncol; 2000 May; 7(4):305-11. PubMed ID: 10819372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low angiomotin-p130 with concomitant high Yes-associated protein 1 expression is associated with adverse prognosis of advanced gastric cancer.
    Hong SA; Son MW; Cho J; Jang SH; Lee HJ; Lee JH; Cho HD; Oh MH; Lee MS
    APMIS; 2017 Nov; 125(11):996-1006. PubMed ID: 28885730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YAP1 overexpression is associated with poor prognosis of breast cancer patients and induces breast cancer cell growth by inhibiting PTEN.
    Guo L; Chen Y; Luo J; Zheng J; Shao G
    FEBS Open Bio; 2019 Mar; 9(3):437-445. PubMed ID: 30868052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of YAP1 in EGFR mutant lung adenocarcinoma prior to tyrosine kinase inhibitor therapy is associated with poor survival.
    Hong SA; Jang SH; Oh MH; Kim SJ; Kang JH; Hong SH
    Pathol Res Pract; 2018 Mar; 214(3):335-342. PubMed ID: 29487002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Yes-Associated Protein 1 (YAP1) in Various Cancers: A Meta-Analysis.
    Sun Z; Xu R; Li X; Ren W; Ou C; Wang Q; Zhang H; Zhang X; Ma J; Wang H; Li G
    PLoS One; 2015; 10(8):e0135119. PubMed ID: 26263504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Yes Associated Protein 1, an Independent Prognostic Marker in Patients With Pancreatic Ductal Adenocarcinoma, Correlated With Liver Metastasis and Poor Prognosis.
    Salcedo Allende MT; Zeron-Medina J; Hernandez J; Macarulla T; Balsells J; Merino X; Allende H; Tabernero J; Ramon Y Cajal S
    Pancreas; 2017 Aug; 46(7):913-920. PubMed ID: 28697132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer.
    Pallocca M; Goeman F; De Nicola F; Melucci E; Sperati F; Terrenato I; Pizzuti L; Casini B; Gallo E; Amoreo CA; Vici P; Di Lauro L; Buglioni S; Diodoro MG; Pescarmona E; Mazzotta M; Barba M; Fanciulli M; De Maria R; Ciliberto G; Maugeri-Saccà M
    J Transl Med; 2018 Sep; 16(1):247. PubMed ID: 30180862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of nuclear Yes-associated protein 1 in patients with nonsmall cell lung cancer: A systematic review and meta-analysis.
    Zhu L; Ma G; Liu J; Deng Y; Wu Q; Chen W; Zhou Q
    Medicine (Baltimore); 2019 Apr; 98(16):e15069. PubMed ID: 31008931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physalin A, 13,14-Seco-16, 24-Cyclo-Steroid, Inhibits Stemness of Breast Cancer Cells by Regulation of Hedgehog Signaling Pathway and Yes-Associated Protein 1 (YAP1).
    Ko YC; Choi HS; Liu R; Lee DS
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma.
    Dai H; Shao YW; Tong X; Wu X; Pang J; Feng A; Yang Z
    Cancer Med; 2020 Mar; 9(5):1628-1637. PubMed ID: 31851786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis.
    Kang W; Tong JH; Chan AW; Lee TL; Lung RW; Leung PP; So KK; Wu K; Fan D; Yu J; Sung JJ; To KF
    Clin Cancer Res; 2011 Apr; 17(8):2130-9. PubMed ID: 21346147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome.
    Rybarczyk A; Klacz J; Wronska A; Matuszewski M; Kmiec Z; Wierzbicki PM
    Oncol Rep; 2017 Jul; 38(1):427-439. PubMed ID: 28504812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.